Alterity Therapeutics Ltd.

Biotechnology • Healthcare • Melbourne, VIC, United States • PRNAF (PNK)

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Alterity Therapeutics Limited's (ASX:ATH) Path To Profitability - Yahoo Finance

Yahoo Finance • Oct 11

Neurodegenerative Disease Biotech Alterity Therapeutics Sets Corporate Update at Global Showcase - Stock Titan

Stock Titan • Sep 2

Alterity Therapeutics Reports Positive ATH434 Phase 2 Trial Results at 2025 MDS Congress - TipRanks

TipRanks • Oct 9

We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth - Yahoo Finance

Yahoo Finance • Aug 31

Alterity (NASDAQ: ATHE) presents Phase 2 ATH434 MSA: OH stable; placebo worsened 6 points - Stock Titan

Stock Titan • Nov 10

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has ALTERITY THERAPEUTICS LTD had layoffs?

No layoff events have been recorded for ALTERITY THERAPEUTICS LTD in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does ALTERITY THERAPEUTICS LTD have?

ALTERITY THERAPEUTICS LTD has approximately 9 employees.

What industry is ALTERITY THERAPEUTICS LTD in?

ALTERITY THERAPEUTICS LTD operates in the Biotechnology industry, within the Healthcare sector.

Is ALTERITY THERAPEUTICS LTD a publicly traded company?

Yes, ALTERITY THERAPEUTICS LTD is publicly traded under the ticker symbol PRNAF on the PNK. The company has a market capitalization of approximately $0.07 billion.

Where is ALTERITY THERAPEUTICS LTD headquartered?

ALTERITY THERAPEUTICS LTD is headquartered in Melbourne, VIC, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.